par 511 Pill - white capsule/oblong, 10mm
Pill with imprint par 511 is White, Capsule/Oblong and has been identified as Minocycline Hydrochloride 50 mg. It is supplied by Par Pharmaceutical Inc.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bullous Pemphigoid; Bartonellosis; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par 511
Minocycline Hydrochloride
- Imprint
- par 511
- Strength
- 50 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc.
- Inactive Ingredients
-
microcrystalline cellulose,
lactose anhydrous,
magnesium stearate,
sodium starch glycolate type A potato,
titanium dioxide,
polyethylene glycol 400,
polysorbate 80,
povidone k30,
silicon dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0589 | AvKare, Inc. |
| 49884-0511 (Discontinued) | Par Pharmaceutical, Inc. |
| 60429-0333 | Golden State Medical Supply (repackager) |
Related images for "par 511"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Emrosi, Dynacin, Ximino, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Emrosi, Minocin for Injection, Ximino, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.